Psilocybin Leads in Psychedelic Medicine, but Rollout Is Bumpy

The New York TimesTuesday, January 13, 2026 at 10:01:27 PM
NeutralHealth
Psilocybin Leads in Psychedelic Medicine, but Rollout Is Bumpy
  • Psilocybin-assisted therapy has been legalized in three states, yet access remains limited and costly, as evidenced by Dr. Bonny Koeber preparing a therapy room with sage for a patient traveling from New York to Satya Therapeutics in Ashland, Oregon.
  • The challenges in the rollout of psilocybin therapy highlight the need for improved accessibility and affordability in psychedelic medicine, which could impact the future of mental health treatment and the operations of facilities like Satya Therapeutics.
— via World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended apps based on your readingExplore all apps

Ready to build your own newsroom?

Subscribe to unlock a personalised feed, podcasts, newsletters, and notifications tailored to the topics you actually care about